The next generation virus‐like particle platform for the treatment of peanut allergy

Background Allergy to peanut is one of the leading causes of anaphylactic reactions among food allergic patients. Immunization against peanut allergy with a safe and protective vaccine holds a promise to induce durable protection against anaphylaxis caused by exposure to peanut. A novel vaccine cand...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Allergy (Copenhagen) Ročník 78; číslo 7; s. 1980 - 1996
Hlavní autoři:	Sobczak, Jan M., Krenger, Pascal S., Storni, Federico, Mohsen, Mona O., Balke, Ina, Reseviča, Gunta, Heath, Matthew D., Carreno Velazquez, Thalia L., Kramer, Matthias F., Scott, Callum J. W., Skinner, Murray A., Zeltiņš, Andris, Kündig, Thomas M., Vogel, Monique, Bachmann, Martin F.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Denmark Blackwell Publishing Ltd 01.07.2023
Témata:	Allergens Allergies Anaphylaxis Animal models Animals Antigens, Plant Ara h 2 antigen Arachis capsid cross immunity Cucumber mosaic virus Epitopes Food allergies Immunization Immunogenicity Immunoglobulin G Immunotherapy Mice novel therapy peanut allergy Peanut Hypersensitivity - prevention & control peanuts Prospective Studies T-lymphocytes vaccination vaccine Vaccines Viruses virus‐like particles peanut allergy virus-like particles vaccine novel therapy
ISSN:	0105-4538, 1398-9995, 1398-9995
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!